about
Alpers-Huttenlocher syndromeFollow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns-Sayre syndrome.MRI in headache.The many faces of paediatric mitochondrial disease on neuroimaging.A multicenter study on Leigh syndrome: disease course and predictors of survival.Energy failure in multiple sclerosis and its investigation using MR techniques.MDMA administration decreases serotonin but not N-acetylaspartate in the rat brainThe genetics of Leigh syndrome and its implications for clinical practice and risk managementPOLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disordersAutism and intellectual disability associated with mitochondrial disease and hyperlactacidemia.Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment.An interesting case of Leigh-like syndrome.MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing.Mitochondrial disease in childhood: mtDNA encoded.Neuroimaging in mitochondrial disordersClinical and Brain Magnetic Resonance Imaging Features in a Cohort of Chinese Patients with Kearns-Sayre Syndrome.Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Child neurology: a case illustrating the role of imaging in evaluation of sudden infant deathPseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination.Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers.Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course.Peripheral neuropathy associated with mitochondrial disease in children.The role of mitochondria in axonal degeneration and tissue repair in MS.Leigh syndrome: neuropathology and pathogenesis.When to Suspect and How to Diagnose Mitochondrial Disorders?Widening the Heterogeneity of Leigh Syndrome: Clinical, Biochemical, and Neuroradiologic Features in a Patient Harboring a NDUFA10 Mutation.Imaging of MELAS.Myopathology of Adult and Paediatric Mitochondrial Diseases.Illness-induced exacerbation of Leigh syndrome in a patient with the MTATP6 mutation, m. 9185 T>C.Acquired microcephaly, regression of milestones, mitochondrial dysfunction, and episodic rigidity in a 46,XY male with a de novo MECP2 gene mutation.Leigh syndrome: MRI findings in two children.Assessment of myelination in hypomyelinating disorders by quantitative MRI.A randomized trial of coenzyme Q10 in mitochondrial disorders.Different stages of white matter changes in the original HDLS family revealed by advanced MRI techniques.The aetiology of neonatal seizures and the diagnostic contribution of neonatal cerebral magnetic resonance imaging.Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain.Aberrant synthesis of ATP synthase resulting from a novel deletion in mitochondrial DNA in an African patient with progressive external ophthalmoplegia.Early spinal cord and brainstem involvement in infantile Leigh syndrome possibly caused by a novel variant.NEWS and VIEWS: mitochondrial encephalomyopathies.Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.
P2860
Q26830373-9BD9B0A2-1A74-49A1-A74E-5B840BB2EE9DQ30420432-2FE59F07-EDBA-49FF-BC83-8768F968BD17Q30596091-CD5D4A07-877E-478B-B515-85657EE9F25FQ31116989-2C1B3409-27A5-4145-A64A-7C599467ABD8Q33614160-43A7B7BD-F30E-450D-8042-4DFC3D2CBF50Q33928808-2E0FB175-CBFA-4FD8-B973-98078B2F9C19Q34280047-8EB46B1A-F761-472F-BC6B-BC231795FD3EQ34532004-9C184430-3F56-4B6E-B392-01BBAA925777Q34997170-A9C4BF2E-09A3-47D2-BC3C-B896858BBE6DQ35139145-BCE466D2-D962-4F61-B914-4AC31EAB901DQ36055870-7850D350-7FD7-4BB3-8CFB-0452CA032F86Q36543384-4A45EF69-7E7C-4DA9-BF6A-CE7C06DDFB04Q36597189-C683B7A6-E5CE-4564-9EDF-F53FB422959FQ36762842-AFFCA135-09CD-401B-9EC4-C68D8AB77DE1Q36762857-8DF66E06-C807-4379-A471-7AD600C1389BQ37011332-9A2C611A-D659-4F97-BCF2-52303B151475Q37210464-71350FA6-F317-40A6-8CC6-C96C9034AC5AQ37347531-8AC105DD-450F-44C9-8412-7C44812AFD58Q37561288-3C939EEA-4844-4B68-8EEC-4632C1747BE5Q37623186-D681A2E5-0E05-453E-B282-F14C7CD05B28Q37970121-5C43517B-0A2F-4E28-8686-AAE2FB3E7B50Q37995703-C945B32F-2809-4424-8D24-3E6B66C4BE49Q38020826-6C386D18-F330-4CA7-851D-44E5FE7EBFECQ38482925-BA11B39E-9893-4564-8877-1768C87AE6A1Q38694080-4D9894EA-9AA8-4840-9621-69524CA36E09Q38752156-DFE175AC-C61F-4160-82F9-9246CFDAD9A4Q38914260-F25EDD9B-1638-4F22-A6E8-5B80B80AF246Q39414816-39B52CF4-2F1B-4DD7-AD6B-48D2DD8D1781Q40356491-74F1219E-5F61-4CE9-ACE2-9F5F39B293B7Q41937036-15B59D32-7197-4A88-B941-61714703783CQ42176146-2BC7D5E7-6A72-469D-A752-C43C3C77F81EQ42511591-58E61F60-B049-405E-B183-B3D136BE3A79Q42872025-730B396E-6DB6-466A-AB63-200A8F7FED1EQ43636735-55CF6C88-3F1C-4E3F-B35E-B961095BD385Q45408499-4CCD1C53-53A4-4127-898D-F9EB9EE60194Q46037563-D8F8E6D7-4B7A-48A0-8FD9-31015CBC0318Q46174978-3EAFDECD-6C84-4313-9CEE-5F427FCBCA0CQ46188637-E5469F7E-D044-43E4-8912-5FF5AC1CBD54Q46210790-02C3ACEB-BC5C-4AB6-B719-659C3D3DFDAEQ46929110-004FE80F-56B8-48D4-A105-2A26A652CC34
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Neuroimaging of mitochondrial disease.
@ast
Neuroimaging of mitochondrial disease.
@en
Neuroimaging of mitochondrial disease.
@nl
type
label
Neuroimaging of mitochondrial disease.
@ast
Neuroimaging of mitochondrial disease.
@en
Neuroimaging of mitochondrial disease.
@nl
prefLabel
Neuroimaging of mitochondrial disease.
@ast
Neuroimaging of mitochondrial disease.
@en
Neuroimaging of mitochondrial disease.
@nl
P2860
P1433
P1476
Neuroimaging of mitochondrial disease
@en
P2093
Dennis W W Shaw
Russell P Saneto
P2860
P304
P356
10.1016/J.MITO.2008.05.003
P577
2008-05-23T00:00:00Z